To confirm whether the increased soluble TGF-β1 originated from MSCs or CD4+ T cells exposed to LPS and hypoxia stimulation, Tgfb1 mRNA expression of CD4+ T cells sorted from groups of control, ARDS, and MSCs treatment was measured by RT-PCR. The gene discussed is CD4; the disease is acute respiratory distress syndrome.